Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment
BackgroundMild cognitive impairment (MCI) with amyloid PET positivity represents a prodromal stage of Alzheimer’s disease (AD), yet no disease-modifying therapies are currently approved. Ginkgo biloba, traditionally used in East Asian and European ethnomedicine as an oral decoction or standardized e...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1639924/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|